Company Filing History:
2 out of 3,223 
2 out of 4,948 
Years Active: 2021-2023
Title: Cheol Keun Chung: Innovator in Pharmaceutical Chemistry
Introduction
Cheol Keun Chung is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for cancer treatment. With a total of 2 patents to his name, Chung's work exemplifies the intersection of science and innovation.
Latest Patents
Chung's latest patents focus on solid forms of a specific compound, 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol. These patents detail processes for preparing fused tricyclic compounds that include a substituted phenyl or pyridinyl moiety. The formulations and methods described are aimed at enhancing the treatment of cancer, showcasing Chung's commitment to advancing medical science.
Career Highlights
Throughout his career, Cheol Keun Chung has worked with prominent companies in the pharmaceutical industry, including Genentech, Inc. and Hoffmann-La Roche Inc. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research.
Collaborations
Chung has had the opportunity to work alongside talented individuals such as Jie Xu and Hans Iding. These collaborations have enriched his research and fostered an environment of innovation.
Conclusion
Cheol Keun Chung's contributions to pharmaceutical chemistry and his innovative patents reflect his dedication to improving cancer treatment. His work continues to inspire future advancements in the field.